UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Aug

    12

    Our Growth Helps Elevate Patient Lives

    Read More Share:linkedin| twitter| email| facebook

    Aug

    05

    UCB’s HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment

    Read More Share:linkedin| twitter| email| facebook

    Aug

    01

    Beyond Awareness: Uniting for a Brighter Future at the HS Summit

    Read More Share:linkedin| twitter| email| facebook

    Jul

    31

    Strength in Connection: The Role of Supportive Networks in Psoriatic Disease

    Read More Share:linkedin| twitter| email| facebook

    Jul

    30

    Building Talent, Shaping Futures: Why Interns Matter

    Read More Share:linkedin| twitter| email| facebook

    Jul

    08

    UCB extends its BIMZELX® “Get Yourself Back” direct-to-consumer campaign for the hidradenitis suppurativa community

    Read More Share:linkedin| twitter| email| facebook

    Jun

    27

    UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

    Read More Share:linkedin| twitter| email| facebook

    Jun

    20

    UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference

    Read More Share:linkedin| twitter| email| facebook

    Jun

    17

    Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.

    Read More Share:linkedin| twitter| email| facebook

    Jun

    13

    Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis

    Read More Share:linkedin| twitter| email| facebook

    © 2009 - 2025 UCB, Inc. Atlanta. All rights reserved. 
    Last updated: August 2025